Related Experiment Videos

Restenosis after percutaneous transluminal coronary angioplasty

H K Pedersen1, K Vatne, S Simonsen

  • 1Department of Radiology, National Hospital, University of Oslo, Norway.

Acta Radiologica (Stockholm, Sweden : 1987)
|March 1, 1992
PubMed

Insights

Restenosis, a complication of percutaneous transluminal coronary angioplasty (PTCA), affects 29% of patients, often within 4 months, especially in smaller arteries. Early follow-up and redilation are key management strategies.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for treating coronary artery disease.
  • Restenosis, the re-narrowing of a treated artery, remains a significant limitation of PTCA.

Purpose of the Study:

  • To investigate the incidence and timing of restenosis after successful PTCA.
  • To identify patient and arterial factors associated with restenosis.
  • To evaluate the safety and efficacy of redilation as a treatment for restenosis.

Main Methods:

  • Retrospective analysis of 210 patients who underwent successful PTCA.
  • Clinical follow-up to assess for restenosis.
  • Subgroup analysis based on arterial diameter and time to restenosis.

Main Results:

  • Restenosis occurred in 61 (29%) of the 210 patients.
  • The majority of restenosis events happened within 4 months post-PTCA.
  • Restenosis was more frequent in arteries with a diameter less than 3 mm.

Conclusions:

  • Close clinical monitoring is crucial in the early period after PTCA, particularly for smaller coronary arteries.
  • Redilation can be safely performed in cases of restenosis without increasing the risk of further restenosis.

Related Concept Videos